What is a malignant fibrous histiocytom?

Malignant fibrous histiocytoma, or MFH, is cancer that grows from soft tissues or bones. He is a member of the cancer group known as sarcomas and malignant fibrous histiocytoma is the most common sarcoma of soft tissues found in the older adult population. Treatment usually involves surgery and radiotherapy and sometimes chemotherapy. The drug is possible if the cancer can be fully removed before expansion. It occurs most often on the arm or leg, although cancer may come in any area of ​​the body. The scanning of magnetic resonance imaging or MRI scanning is often used to obtain a tumor image, indicating its structure and its spread range. In order to study real tumor cells that distinguish malignant fibrous histiocytoma from other types of cancer, a biopsy is usually required. Here, the needy is introduced into the tumor and the cell sample is removed, which can then be examined under the microscope.

forMalignant fibrous histiocytomas have variable views depending on whether the tumor has already spread to other parts of the body and how large and aggressive is cancer. Larger and more aggressive tumors lead to a lower survival rate, and if cancer has spread or metastasizes, this means that the prognosis is poor. The most common area of ​​the body to which the malignant fibrous histiocytoma spreads is the lungs.

Surgery is the main type of treatment associated with malignant fibrous histiocytomas, and although in the past it could include amputation of the affected limb, now it is now unusual and the limb is usually stored if possible. In addition, radiation therapy is generally administered and this treatment can be performed either before, during, or as the most common, after surgery. Chemotherapy is not always beneficial, but may be useful in some cases and research is carried out in new and potentially more efficient treatment regimens for this type of cancer by chemotherapy.

malignant fibrous histiocytomaHe has been reclassified by the World Health Organization because it is now assumed that it is a end phase in the development of a number of different types of tumor, rather than being a disease in itself. It is now referred to as "undifferentiated pleomorphic sarcoma, otherwise it is not specified". Despite this, the original name is still used by doctors and their patients.